Navigation Links
U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Date:1/14/2009

Schering-Plough expects to respond to agency during first quarter

KENILWORTH, N.J., Jan. 14 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS(TM) (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy. The action letter includes proposed labeling for both indications and a request for supplemental data from the existing asenapine database. No additional clinical trials have been requested. The Company anticipates providing the requested information to the agency in the first quarter of 2009.

"We are pleased with the progress on the SAPHRIS filing and look forward to working with the agency to address its request, finalize the product labeling and gain approval," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute. "New treatments are needed in this therapeutic area and we believe that asenapine has the potential to be an important option in addressing this need."

Schering-Plough acquired asenapine in November 2007 through its acquisition of Organon BioSciences, which developed the antipsychotic agent. The New Drug Application (NDA) for asenapine includes data from a clinical trial program involving more than 3,000 patients in schizophrenia and bipolar mania trials.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to hum
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
2. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
3. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
4. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
5. U.S. FDA Issues Action Letter for Sugammadex
6. European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
7. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
8. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Xcelience, a contract ... it has made a structured cash investment in ... specializing in milling, micronization and powder size classification ... grow Powdersize,s business while simultaneously adding a complete ... portfolio of capabilities. "As we ...
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
(Date:8/3/2015)... ... 03, 2015 , ... Cambia Health Solutions has promoted Scott ... company’s Medicare and Federal Employee Programs (FEP) lines of business. , Government ... members. In this role, Scott is responsible for overseeing the growth, finance and ...
(Date:8/3/2015)... ... August 03, 2015 , ... The American Institute of ... agreement to collaborate across a wide range of initiatives ranging from code development ... architects. , “Our combined membership, consisting of practicing design professionals, code officials, and ...
(Date:8/2/2015)... , ... August 03, 2015 , ... ... will be attending and exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) ... , “We are pleased for the opportunity the AHDI conference provides us to ...
(Date:8/2/2015)... Michigan (PRWEB) , ... August ... ... (POP) results when the supportive muscles and connective tissues of a woman’s ... this weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be dangerous? Whaaat?! , ... packs can wreck havoc on a kid's spine. With school starting again, most kids ... school. Make sure you are aware of how to help them prevent injuries by ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2
... , , ... , , ATLANTA, Sept. 11 Atlanta-based indoor ... as the only laboratory in the United States to perform office ... is the oldest and most respected eco-label in the world. ...
... Sept. 11 Corgenix Medical Corporation (OTC Bulletin Board: CONX), a ... conference call on Friday, September 25, 2009, at 4:00 PM EDT ... year ended June 30, 2009, and the status of the Company,s ... Corgenix invites all those interested in hearing management,s discussion of the ...
... alone doesn,t measure severity of cases, researchers say , FRIDAY, ... value of hospital report cards and national rankings when it ... Health System in Chicago say the mortality index, a statistic ... a given area of medical care, may be inflated -- ...
... infection tends to strike young adults, expert says , ... has been focused on getting vaccinated for both the ... nationwide effort has been launched to highlight the need ... sometimes deadly infection that tends to strike teenagers and ...
... ... at the lowest prices possible. To maintain high quality standards and ensure consumer trust, ... of product safety and efficacy. , ... Fargo, ND (Vocus) September 11, 2009 -- Last month ConsumerLab.com (CL), ...
... , , , , ... of Celebratory Events , , VALHALLA, N.Y., ... the advanced care pediatric facility serving New York,s Hudson Valley region ... September and will commemorate the milestone with a year-long series of ...
Cached Medicine News:Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 2Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 3Health News:Report Cards for Hospitals May Be Misleading 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 3Health News:Swanson Health Products' Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab.com 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 3
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
... pending solution using Radio Frequency Identification ... label to promote patient safety by ... surgery. This simple to use system ... with the operating room staff in ...
... facilities, recreational venues and more can ... automated data capture that boosts efficiency ... dangerous errors. RFID wristbands can also ... entertainment venues as well as be ...
... The optional Kisses component ... designed to assist nursing staff ... mothers while in the hospital. ... you have an easy, effective ...
Medicine Products: